Nuclear Medicine and Biology

Papers
(The median citation count of Nuclear Medicine and Biology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Automated One-pot and One-step Radiosynthesis of [18F]VAT for PET Imaging of Vesicular Acetylcholine Transporter49
Preclinical Evaluation of [18F]F-[natLu]Lu-DOTA-rhCCK-18, the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with high Target Affinity and Tumor Accumulation34
177Lu and 227Th Labeled 3,4,3-(LI-1,2-HOPO): characterization, optimized synthesis, biological distribution and dosimetry28
Development of a novel Azabenzimidazoles-Based PET radioligands for γ-8 dependent transmembrane AMPA receptor regulatory protein imaging25
Longitudinal florzolotau (18F) PET study in a rat model of Alzheimer’s disease.25
Radiofluorination of Sterically Hindered Amides: Automation, Stability Studies, and Mechanism22
N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/21
Versatile diphosphine platforms for molecular radio-pharmaceuticals based on technetium-99m and rhenium-18819
[11C]HSP990 PET as a translational tool to investigate the aberrant role of Hsp90 in tumors and support the development of Hsp90 therapeutics19
Synthesis of a porphyrin-PSMA conjugate and preliminary labelling with copper-6419
Improving PET imaging of urothelial carcinoma using manual synthesis of [68Ga]Ga-FAPI-46 and automated synthesis of [18F]AlF-FAPI-7417
Status of radiobiology in molecular radionuclide therapy – Hope for the future16
Preclinical evaluation of [155/161Tb]Tb-crown-TATE – a novel SPECT imaging agent targeting neuroendocrine tumors16
An orthogonal labeling strategy to accelerate bioconjugation of [99mTc]Tc-building blocks15
Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy14
Editorial Board13
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information13
Impact of Different 177Lu Sources and Precursor Variations on the Quality of 177Lu-Labeled Theranostics12
Electroamalgamation-and Chromatography-Based Eu/Tb Separation Procedures as a Proof of Concept for Separating 155Tb from Alpha-Irradiated 153Eu12
18F-labelling of T cells for in vivo evaluation of CAR T cell therapy12
Protocol for Automated Production of Radiofluorinated Boramino Acids12
Preclinical and Initial Clinical Evaluation of 68Ga/177Lu-Labeled Heterodimer Agents Targeting both Somatostatin Receptor and Integrin αVβ311
Development of an Automated [18F]FBPA Synthesis Using a Commercially Available Precursor11
Enhancing Tumor Uptake Efficiency of Radioimmunoconjugates through DLS-Based Aggregation Detection and Removal11
A new, optimised diphosphine chemical platform for kit-based, receptor-targeted 99mTc and 188Re radiopharmaceuticals11
A fully automated synthesis of [18F]Fluro-L-meta-tyrosine (FMT) on AllInOne synthesizer11
Optimization and Routine Production of Gallium-68-Radiolabeled Agents Using a Cyclotron Liquid Target System and Automated Radiosynthesis11
Domestic Production of Therapeutic Isotopes Via Fusion10
Radiosynthesis and first in vitro evaluation of [11C]Onalespib for Hsp90 cancer imaging10
Medical Radionuclide Production Using Nuclear Fusion10
Radiosynthesis of Primary Amides Through 11C-Carbonylation by [11C]Carbon Monoxide Using GE FX Synthesis Modules10
ATP Synthase is a Promising Target for Non-Invasive Imaging of Activated and Non-activated Adipose Tissues10
Evaluation of Antibody-Based TREM2 PET in Mice: Contrasting Image-Derived Blood Normalization with the Standard %ID Normalization Method10
Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen9
Radiolabeling yield dependency of post-dry distillation decay of astatine-2119
Non-invasive imaging of neutrophils in acute sepsis9
Retraction notice to “Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors”. [N9
Combining High-Throughput Radiochemical Experimentation Techniques with “Design of Experiments” (DoE) to Accelerate the Radiosynthesis Optimization of Novel Radiopharmaceuticals9
Mitochondria-targeted radiocomplexes for cancer theranostics9
Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes9
Rhenium and technetium complexes in extremely low oxidation states9
Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH9
Exploring the potential of high-specific activity samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE8
[11C]Vercirnon - a candidate PET radioligand for the CCR9 chemokine receptor8
Next generation copper complexes for efficient production of radiolabeled aromatics8
Targeting brain tumours with radiolabelled chlorotoxin, a scorpion venom peptide8
Preclinical evaluation of [68Ga]Ga-BCY18469, a first-in-class EphA2-targeting radiotheranostic Bicyclic Peptide8
89Zr-immuno-PET guided preclinical development of targeted therapies: demonstrating utility by evaluating fusion proteins in vivo8
177LuIII- and 225AcIII-labelled bispidine-TATE conjugates: promising candidates for targeting neuroendocrine tumours7
Development of Electrolytic Labeling of 211At to Iodotyrosine Derivatives7
A novel bispecific antibody for the enhanced delivery of radiopharmaceuticals to brain tumours7
Introduction of terbium-161 into the clinics through its automated purification and the Good Manufacturing Practice compliant production of [161Tb]Tb-DOTA-LM37
The theranostic Goldilocks radionuclide copper-67 produced at a biomedical cyclotron7
Non-Canonical Amino Acids Substitutions Modulate Biodistribution and Tumor Accumulation of FAP-Targeted Cyclic-peptide Radiotracers7
Development and radiolabelling of fluorinated ligands targetting the Aryl hydrocarbon Receptor7
Editorial Board7
Design and Preclinical Evaluation of 68Ga-Labeled Covalently Modified Nectin-4 Targeting Peptide as a Potential Tumor Radiotracer7
An efficient, versatile procedure for the [18F]-radiofluorination of base-sensitive tracers with high radiochemical conversion7
Evaluation of [18F]TzPheBF3 cell uptake and intracellular iEDDA reactivity through in vitro studies using Hoechst-TCO6
18F-MGX-110S detects proinflammatory innate immune responses in human cells and Alzheimer’s disease mice with high sensitivity6
Development of novel 18F-PET imaging probes for mTOR signaling in Focal cortical Dysplasia type II6
Fully automated and optimized [68Ga]Ga-NODAGA-Exendin-4 radiolabelling process on the TRASIS miniAllinOne6
Imaging Glucose Metabolism and Dopaminergic Dysfunction in Sheep (Ovis aries) Brain Using Positron Emission Tomography Imaging Reveals Abnormalities in OVT73 Huntington’s Disease Sheep6
Validation of an HPLC method for assessing the chemical and radiochemical purity of [18F]Sodium Fluoride radiopharmaceutical6
Development of an HCAR1 radiotracer6
Surface Marker Diversity on Circulating Tumor Cells in Advanced Prostate Cancer Patients6
The development of [18F]-LQ-1-41 as a PET tracer for imaging KRAS G12D tumors6
Girentuximab (TLX250) as a theranostic tool in triple-negative breast cancer treatment6
Expression of concern “cross sections of the 226Ra(p,xn) reactions relevant for 225Ac production“5
Novel Radiofluorinated Analogues of GSK321 for PET Imaging of mIDH1 in Gliomas5
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information5
Study of activation cross sections of double neutron capture reaction on 193Ir for the reactor production route of radiotherapeutic 195mPt5
[18F]FMISO-PET imaging reveals the role of hypoxia severity in checkpoint blockade response5
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information5
GTP1 metabolic stability assessment: A study of the tau PET tracer [18F]GTP15
New prospects for 89Zr-immuno-PET in brain applications – Alpha-synucleinopathies5
Editorial Board5
A decade of ubiquicidin development for PET imaging of infection: A systematic review5
Title Page5
Current developments in the production of actinium-225 from thorium-2294
Clinical grade [15O]O2 Production for Human Inhalation PET/MRI study4
Identifying Lymph Node Metastasis in High Grade Serous Ovarian Cancer Mouse Models via ImmunoPET Imaging4
[55Co]Co-DOTA-SP4: Towards NK1R-targeted Theranostics of Glioblastoma4
Abstract withdrawn.4
Automation of two-step one-vessel ditosylate synthon fluorination using Trasis AllinOne4
Inorganic ion molar absorptivity at higher energy UV wavelengths and how it affects high performance liquid chromatography results4
Biodistribution of [18F]BCPP-BF in humans: a first-in-human positron emission tomography study4
Developing a Novel Microfluidics-based 86Y Purification Strategy for Rapid and Efficient Radiopharmaceutical Production4
Preclinical evaluation of [111In]In-labeled GRPR-targeting DB15 mimics for potential theranostic use in prostate cancer4
Folate receptor targeted 64Cu/ICG-labeled layered double hydroxide nanoprobe for PET/CT and NIRF imaging4
89Zr-radiolabeling of p-NCS-Bz-DFO-anti-HER2 affibody immunoconjugate and in vitro assessment of its potential in HER2+ breast cancer imaging3
Synthesis of Bifunctional Macrocyclic Chelator3
Cancer stem cell targeted short peptide for PET imaging using Cu-64 in breast cancer cell xenografted model3
Recent advances in understanding and improving the stability of 211At-radiopharmaceuticals3
Evaluation of chelating agents based on pyridine-azacrown compounds H4PATA, PATAM, and H4PATPA for 68Ga and 177Lu3
Large Chelators for Large Radiometals: Endeavors to Complex Radium-223 and Barium-131 to Advance Targeted Alpha Therapy and Theranostics of Cancer3
Automated Purification of 64Cu with the GE FastLab For GMP Production3
Radio-HPLC for 225Ac-Radiopharmaceuticals: Considerations on the Retrospective Reconstruction of the 225Ac-Specific Radio-Chromatogram by Three Different Methods3
Radiosynthesis and evaluation of a new PET tracer for imaging of leucine-rich repeat kinase 23
Targeted Alpha Therapy of Ovarian Cancer with ²¹²Pb-Labeled Anti-PTK7 Antibody: Efficient Production at Non-Clinical Scale and Preclinical Insights3
Trithiol ligand provides tumor-targeting 191Pt-complexes with high molar activity and promising in vivo properties3
Editorial Board3
Comparative radiobiology of human leukemia cells and opportunistic fungal cells post treatment with 225Ac- and 177Lu-radiolabeled antibodies3
Design of innovative FAP-target modules for simultaneous delivery of CAR-T cell-and radiotherapy3
Synthesis of novel PSMA ligands and preclinical evaluation of [99mTc]TcO-ABX474, a radioligand for SPECT imaging of prostate cancer3
Demonstrating targeted delivery of an antisense oligonucleotide (ASO) to pancreatic insulin secreting-cells in non-human primates using positron emission tomography3
Development of Targeted Theranostics through Clinical Applicability Validation based on Pancreatic Cancer Patient-derived Organoid Platform3
Synthesis and preclinical evaluation of [18F]AlF-NODA-MP-C6-CTHRSSVVC as a PET tracer for CD163-positive tumor-infiltrating macrophages3
development of novel fap inhibitors for cancer imaging and therapy: from rapid uptake to prolonged retention3
Evaluation of Direct and Pretargeting Approaches for CD38 PET Imaging in NSCLC Mouse Model with Isatuximab Fragment2
Imaging resistance to anti-androgens in prostate cancer by multimodal 13C-pyruvate hyperpolarized magnetic resonance spectroscopy and 18F-pivalate positron emission tomography2
Ultra-fast and efficient conversion of [11C]CO2 into [11C]hydantoins via the Bucherer-Bergs multicomponent reaction2
Target occupancy studies of rho-associated protein kinase inhibitors in nonhuman primate with [11C]ROCK201 PET2
The development of [11C]M503-1619 as a PET tracer for imaging α-synucleinopathies in Parkinson’s disease (PD)2
Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET2
Filtration of Blood for Radiometabolite Analysis in Human Subjects2
Editorial Board2
Scale up production and purification of high specific activity lead-203 (203Pb)2
Investigations of terbium-161 towards prostate cancer therapy using albumin-binding and standard PSMA ligands2
Low-dose targeted alpha therapy induces strong anti-tumor effectiveness in combination with immune checkpoint inhibitors2
Pretargeted PET imaging of trans-cyclooctene functionalized spherical nucleic acids2
2,6-Bis-(N-hydroxylamino)-1,3,5-triazines as ligands for 45Ti-chelation2
Optimal energy interval for the cyclotron production of 68Ga using solid targets2
Targetry of 152Tb PET radioisotope, member of theranostic isotopes of Terbium2
The development of a new type 103Pd/103mRh generator like cold brew coffee2
Correlation of hypoxia PET tracer uptake with hypoxic radioresistance in cancer cells: PET biomarkers of resistance to stereotactic radiation therapy?2
The Next Generation of Tumour Homing Peptides: Foldamers at the Forefront of Precise Cancer Theranostics2
Development of [18F]DASA-10 for enhanced imaging of pyruvate kinase M22
Chemokine receptor PET imaging: Bridging molecular insights with clinical applications2
Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist2
Quality assessment of cyclotron-produced 67Cu2
Development of small molecule PET-tracers targeting PD-L12
The development of terbium-155 and terbium-161 towards radiotheragnostic clinical applications2
Development of a PSMA Heterogeneous Tumor Model for Targeted Radiotherapy2
Recovery and purification of Zn-68 after cyclotron irradiation and Ga-68 recovery2
Rapid copper-mediated radiosynthesis optimization for a novel monoacylglycerol lipase PET tracer on a high-throughput microdroplet radiochemistry platform2
Preclinical evaluation of two new neutrophil elastase inhibitors synthesized by palladium-mediated [11C]cyanations2
43Sc and 44Sc radiolabelling of biomolecules and their use in PET imaging2
Quality Control of Therapeutic Radiopharmaceuticals: Assessment of Quality Control and In Vivo Biodistribution of Radiolysed [177Lu]Lu-PSMA-I&T2
Studies of [89Zr]ZrDFO*-Labeled Human Serum Albumin Applying Different Cysteine Bioconjugation Chemistry2
Comparison of 89Zr-Lumi804-IAB2MA and 89Zr-DFO-IAB2MA for PSMA-targeted PET Imaging of Prostate Cancer2
The importance of radiochemical purity: Cellular binding and internalization of different radiometal chlorides in prostate cancer cells2
Enhanced tumor retention of the novel LAT1-targeting PET probe [18F]FAMT-OMe: A comparative study with [18F]FAMT in glioma mouse models2
225Aс/213Bi generator for direct synthesis of 213Bi-labeled bioconjugates2
Clinical translation of the GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26 for targeting prostate tumors2
A fluorescent probe as a lead compound for a selective α-synuclein PET tracer: development of a library of 2-styrylbenzothiazoles and biological evaluation of [18F]PFSB and [18F]MFSB2
Development of Astatine-211 labeling reaction using aryliodonium ylide2
Synthesis and preclinical evaluation of 99mTc sandwich complexes targeting LAT1 and CRBN2
Corticolimbic activation patterns during aversive audiogenic stress assessed by cerebral perfusion using [99mTc]HMPAO SPECT/CT2
Corrigendum to “radiation dosimetry of the 18 kDa translocator protein ligand [18F]PBR111 in humans” [nuclear medicine and biology, 144–145 (2025); 109,011]2
Synthesis, Dosimetry and Pharm/tox studies of MAO-B Analogue ([11C]COU) for Positron Emission Tomographic Studies1
Preclinical evaluation of 68Ga-labeled folic acid conjugates for visualization of inflammatory foci1
Determination of sorption limit values of ion exchange resins used in the production of yttrium chloride Y-901
Laminated holmium-166-containing electrospun bandages for use against skin cancer1
Streamlined Synthesis of [18F]FSPG on the GE FASTlab™ 2 Platform for Preclinical and Clinical Applications1
Development of [68Ga]Ga-DOTA-4AH29, a radiolabeled single-domain antibody for PET imaging of FAP-α expression in cancer1
Imaging with Nanobody-based bimodal PET/fluorescence tracers for improved clinical decision making1
Screening of mitochondrial dysfunction imaging radiopharmaceutical by targeting NDUFS1 using GCN and LSTM network1
Production of [18F]fluoromannitol facilitated by solid phase flow chemistry toward PET Imaging of bacterial Infections1
CycloSiFA - Towards the Next Generation of Silicon-Fluoride Acceptor based Positron Emission Tomography (PET) Imaging Probes1
D2 – Enabling a theranostic approach with 89Zr/177Lu in a single trifunctional ligand scaffold1
Peptide turn mimics formed by the coordination of Tc:Re-tricarbonyl1
Comparative evaluation of radiolabeled bombesin analogs [177Lu]Lu-AMBA and [177Lu]Lu-RM2 for targeting GRPR in glioblastoma model1
Bispidin-9-ol derivatives for copper-64:67 radiolabeling and facile biofunctionalization strategies1
CONTENTS1
103Ru/103mRh Auger electron emitter generator: a proof of concept1
Development of noninvasive measurement for monoacylglycerol lipase activity in the brain using positron emission tomography1
cGMP synthesis of 4-[18F]fluoro-1-naphthol, a novel PET tracer for imaging activation of innate immunity1
In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR41
Metabolic profiling of mAChR ligands: In silico simulation vs LC-HRMS analysis1
[89Zr]ZrCl4 for direct radiolabeling of DOTA-based precursors1
Characterization of a new Cu selective resin for the separation of Cu from Ni and Zn targets1
ImmunoPET for mesothelin positive tissues using bio-orthogonal in-vivo click chemistry1
Evaluation of 177Lu-DOTA-obinutuzumab as a new radionuclide therapeutic agent for CD20-expressing non-Hodgkin lymphoma1
Preliminary in vitro evaluation of synaptic density with [3H]UCB-J and the pan-tau ligand [3H]OXD-2314 in chronic traumatic encephalopathy.1
Separation of cyclotron-produced cobalt-55/58 m from iron targets using cation exchange chromatography1
Evaluation of in vivo behavior of Na[F-18]F as a single substance and Na[F-18]F-contained mouthwashes via intra-trachea instillation1
Enhancing anti-interleukin-6 antibody immunoPET and radiotherapy with chemotherapy1
Myocardial kinetics of [11C]β-hydroxybutyrate in healthy pigs: Comparison of positron emission tomography imaging vs. arteriovenous balance methods1
Synthesis and evaluation of an 18F-labeled PSMA-targeting tracer for imaging prostate cancer with positron emission tomography1
Evaluation of tetramethylammonium salts in minimalist-like SNAr radiofluorinations1
Copper-mediated radiofluorination: A battle against protodeboronation1
A cassette-based process for the multidose production of [11C]Acetate on the AllinOne1
Implementation and optimisation of scandium-44 and manganese-52 production at King’s College London for preclinical research1
Preclinical evaluation of [225Ac]Ac-crown-TATE – An alpha-emitting radiopharmaceutical for neuroendocrine tumors1
Initial insights into the interaction of antibodies radiolabeled with Lutetium-177 and Actinium-225 with tumor microenvironment in experimental human and canine osteosarcoma1
Practical considerations on the production of copper radioisotopes from enriched liquid targets: a five years’ experience1
Development of Potential 18F-labelled Radiotracers for Imaging of Mutant Huntingtin Fibrils in Huntington’s Disease1
Production of no-carrier-added holmium-166 by double neutron capture reaction at McMaster University research reactor1
Imaging and targeting S1PR1 in HER2+ tumors1
Development of [64Cu]Cu-NGUL and [67Cu]Cu-NGUL as a matched-pair theranostic for prostate cancer1
PET/CT Imaging of avb6 Integrin to Monitor Radiation-Induced Pulmonary Fibrosis1
Dopamine conjugation facilitates optical/PET imaging of polycations in vivo1
Next Generation of Radiopharmaceuticals via Engineering Antibody Derivatives1
Design of novel FAPI Target Modules for simultaneous diagnostic imaging, endoradiotherapy, and UniCAR T-cell immunotherapy1
Investigational Studies on Imaging CSF-1 Receptors in the Brain1
Editorial Board1
Design, synthesis, and biological evaluation of orthosteric ligands for the muscarinic acetylcholine receptors1
Improving the quality of Ga radionuclides to achieve high radiolabeling yields1
Evaluation of 18F-Fluorosulfurylated Fluorescein Derivatives as Hybrid PET/Optical Imaging Agents1
PET imaging of [64Cu]copper(II) chloride and tetrathiomolybdate administration in animal models of triple-negative breast cancer0
Polyacrylamide gel electrophoresis based method for investigation of metabolic stability of [68Ga]Ga-BOT5035 in vitro and in vivo0
A 177Lu-labeled anti-HER2 dual variable domain antibody0
From Bench to Bedside: Advancing Cancer Treatments with Astatine-211 in Europe0
Optimisation of Manufacturing and Quality Control Processes of Radiopharmaceuticals After First-in-Human Studies0
Radiolabeling and preclinical evaluation of [18F]AZ14193052, a novel CNS penetrant and subtype-selective fluorinated PET radioligand for PARP10
Development of a PET ligand [18F]CSF-23 for Imaging of CSF1R in the Brain0
Radiopharmacological comparison of an Al18F- and 68Ga-labeled somatostatin agonist and antagonist in 2D and 3D models of BON-SSTR2 cells0
Towards sustainable radiochemistry: Copper radioisotopes production from ZnO target and Gallium radioisotopes recovery from production waste0
New extractant-impregnated iTLC-SG paper facilitates improved TLC analysis for Cu radiolabelled peptides0
Effects of uncharged linker-modification of PSMA-617-based inhibitors on targeting properties and the pharmacokinetic profile0
Automated Separation of Actinium-225 from Radium-223 Using a Commercial Radiochemistry Module0
Design and evaluation of new 99mTc/188Re-labeled TSPO-binding ligands for cancer theragnostic0
Jugular Vein Access Ports for Radiopharmaceuticals Administration in Preclinical Studies0
Chromophore-conjugated NCS-activated NODAGA is a versatile tool for quantitative prediction of protein-chelator conjugation for 64Cu-immunoPET0
Development of UK Astatine‑211 Production Capability0
Synthesis of [64Cu]Cu+ complex for redox imaging and evaluation of its reactivity with reactive oxygen species0
Editorial Board0
Covalent Modification of Black Phosphorus Nanosheets with 89-Zirconium0
Synthesis and evaluation of a multifunctional probe with a high affinity for prostate-specific membrane antigen (PSMA) and bone0
Development and evaluation of [18F]SEN177 for the detection of glutaminyl-peptide cyclotransferase (QPCT) in the brain0
Application of copper (I) selective ligands for PET imaging of reactive oxygen species through metabolic trapping0
Preclinical development of CD133 targeted immunoPET probes0
Utilizing a 44mSc/44Sc Generator as a Method for 44Sc Distribution0
Identification of non-competitive lead peptides for the development of PET tracers targeting PD-L10
Radiolabeled Microbubbles as a Theranostic Modality in Nuclear Medicine0
Effect of metal impurities on the radiolabeling efficiency of DOTA with terbium-161 and lutetium-177: a comparative study0
11C-MePro PET/CT Imaging in Normal Volunteers: Initial Evaluation of PET-based Human Biodistribution0
Radiobiological effect of alpha particles. The scientific basis of targeted alpha-particle therapy0
Synthesis of Tritium-labeled Lu-PSMA-617: Alternative Tool for Biological Evaluation of Radiometal-based Pharmaceuticals0
Investigation of a GPC-3-addressing peptide as potential radioligand for PET imaging of HCC0
Site-specific 89Zr-labeling of a VHH construct as a half-life extending building block for PET and TRNT applications0
Production of High Specific Activity [203Hg]HgCl2 and Investigation into Storage and Chemical Stability of Synthesised Solutions of [203Hg]HgCH30
A 68Ga-labeled linear peptide-based PET radiotracers for imaging PD-L1 status in tumors0
Prostate Cancer Treatment Using a 177Lu-labeled Gastrin-Releasing Peptide Receptor Antagonist: Monotherapy versus Combination Therapy with Everolimus0
Towards decreased Protodeboronation in the Late-Stage Copper-Mediated Radiofluorination of the Positron Emission Tomography Tracer for Tropomyosin Receptor Kinase [18F]TRACK0
Utilizing Targeted Alpha Therapy and Immunotherapy in PDAC Models0
Modulation of blood pharmacokinetics of 68Ga-labelled nanobody analogues targeting the platelet-derived growth factor receptor beta0
PET Imaging Studies Using [64Cu]-probe in Infective Endocarditis Models Using Various Bacteria0
Development of novel MnO2-based nanoparticles for PET/MRI-guided Alpha Therapy0
Preclinical Insights into [¹⁶¹Tb]Tb-DPI-4452 : A CA IX-Specific Radiopharmaceutical for Targeted Radionuclide Therapy0
Relative Biological Effectiveness (RBE) of [64Cu]Cu and [177Lu]Lu-NOTA-panitumumab F (ab')2 radioimmunotherapeutic agents vs. γ-radiation for decreasing the clonogenic survival in vitro of human pancr0
Editorial Board0
Targeted ROR1 protein degradation combined with PET imaging reveals the role of ROR1 in overcomes EGFR Resistance in NSCLC0
Development of Approaches for High-Throughput Experimentation in Radiochemistry0
Tracking Intravenously Injected Micro- and Nanoplastics with PET0
Bioorthogonal Radiolabeling of GABAAR α1 Subunit-Specific Antibody Fragment for PET imaging0
Determination of Association Constants of Macropa-based Chelators for the Stable Complexation of Barium-131 and Lanthanum-1330
Column-Based Separation of High-Purity 99mTcO4- from Low Specific Activity 99Mo for Radiopharmaceutical Applications0
Development of Solid Target Technologies for 225Ac Production with Proton Bombardment0
0.049985885620117